Independent Medical Education Grant for Transthyretin Amyloidosis supports educators providing clinician education on hereditary disease recognition, diagnosis, and treatment to improve patient care.
AstraZeneca funds independent medical education programs to improve awareness, diagnosis, and treatment knowledge of transthyretin amyloidosis for multidisciplinary healthcare professionals.
Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.
Educational Grants - Alnylam Pharmaceuticals support healthcare professionals and patients through independent education on three rare diseases to advance earlier diagnosis, treatment decisions, and disease management.
Alnylam Pharmaceuticals' CME Grants fund independent, evidence-based education for healthcare professionals on ATTR amyloidosis, AHP, and PH1.
Independent Medical and Patient Education/Advocacy Grants support organizations’ medical education, patient awareness, advocacy, and conference travel initiatives to advance knowledge and improve patient care.